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Abstract 
Two placebo-controlled pen studies were conducted 
to assess the efficacy of an imidacloprid 10 %/flume-
thrin 4.5 % polymer matrix collar (Seresto®, Bayer; 
Investigational Veterinary Product (IVP)) against 
the Australian paralysis tick (Ixodes holocyclus). 
Dogs assigned to the placebo (n = 8) or IVP (n ≥ 8) 
groups had collars (placebo or IVP) attached on Day 
0 and were infested with 30 unfed, adult, female 
I. holocyclus at 14–28 day intervals over 227 days. 
Ticks were counted 24, 48 and 72 h post infestation 
to determine the acaricidal efficacy of the IVP. The 
acaricidal efficacy of the IVP 72 h post infestation 
exceeded 95 % on Days 17 (99.3 %), 59 (99.7 %), 73 
(96.6 %), 87 (100.0 %), 101 (96.4 %), 115 (99.1 %) and 
171 (95.8 %), but dropped on Days 45 (94.0 %) and 
143 (77.8 %), and declined from Day 199 (79.9 %) 
to 227 (65.5 %). No adverse events related to treat-
ment were observed. This study has demonstrated 
the excellent acaricidal efficacy (97.9 %) of the IVP 
collar against I. holocyclus 72 h post infestation 
over 16 weeks.
Introduction 
The adult, female Australian paralysis tick (Ixo-
des holocyclus) injects a neurotoxin (holocyclotoxin) 
into its host as it feeds, with a single tick capable 
of causing paralysis and death in domestic animals 
including dogs and cats. This increases the impor-
tance of effective tick control along the eastern 
coast of Australia, where I. holocyclus is endemic. 
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The incidence of tick paralysis in domestic animals 
is highest in spring and summer, when adult ticks 
are most abundant, but can occur year-round in 
parts of the country and when environmental con-
ditions favour their development. Currently avail-
able options for the control of I. holocyclus on dogs 
are limited and include topically applied spot-ons 
or sprays containing permethrin or fipronil that 
require fortnightly reapplication, or collars con-
taining flumethrin, amitraz or deltamethrin that 
give protection for 6 weeks to 3 months. 
Seresto® (Bayer; Investigational Veterinary Prod-
uct (IVP)) contains imidacloprid (10 %), an insecti-
cide from the chloronicotinyl group of compounds, 
and flumethrin (4.5 %), an ectoparasiticide belong-
ing to the α-cyano-pyrethroids, in a novel polymer 
matrix collar that allows for their slow and con-
tinuous release onto the skin surface and hair coat 
of a treated animal (Stanneck et al. 2012a). The 
IVP is registered for use on dogs and cats in many 
countries including in the European Union, the 
United Kingdom, the United States of America 
and New Zealand. It has been shown to be effica-
cious for 8 months against fleas (Ctenocephalides 
felis felis) and ticks (Amblyomma americanum, 
Dermacentor reticulatus, Dermacentor variabilis, 
Ixodes ricinus, Ixodes scapularis, Rhipicepha-
lus sanguineus and Rhipicephalus turanicus) on 
dogs and cats and additionally eliminates lice 
(Trichodectes canis) and mites (Sarcoptes scabiei) 
on dogs (Stanneck et al. 2012b; Stanneck et al. 
2012c). Both of the active ingredients in the IVP 
are found in ectoparasiticides currently registered 
for use on dogs in Australia. Imidacloprid is an 
efficacious insecticide (Epe et al. 2003; Hellmann 
et al. 2003) and an active ingredient in the topi-
cal spot-ons Advantage® (Bayer Australia Ltd), 
Advocate® (Bayer Australia Ltd) and Advantix® 
(Bayer Australia Ltd) and flumethrin is an effica-
cious acaricide found in the Kiltix® (Bayer Austra-
lia Ltd) collar.
The current study was conducted to determine 
the magnitude and duration of efficacy of the IVP 
against I. holocyclus in dogs.
Materials and methods 
Study design
Two placebo-controlled pen studies were conducted 
at a contract research facility1 to determine the 
efficacy of the IVP against I. holocyclus in dogs, 
from application of the collar on Day 0 until Day 94 
(study 1) and Day 98 until Day 227 (study 2). See 
Table 1 for an overview of the experimental design.
Study animals
The study dogs (study 1, n = 16; study 2, n = 20) 
were mixed-sex foxhounds, 0.7–9.3 years of age, 
weighing 28–55 kg, with an average hair length 
of 15–20 mm over the lateral thorax and abdomen 
and were identified by numbered metal tags and 
implanted microchips. The dogs did not receive an 
acaricide in the 60–90 days prior to study com-
mencement, but were vaccinated and treated 
with a broad-spectrum anthelmintic prior to the 
studies. No routine prophylactic treatments were 
administered during the studies. Dogs were fed a 
maintenance quantity of complete, dry dog food 
once or twice daily, raw bones occasionally and 
had access to clean water. The dogs in the first 
study had an acquired immunity to holocyclotoxin 
induced by frequent infestation with I. holocyclus. 
In the second study, the dogs assigned to the pla-
cebo group were hyperimmunised against holocy-
clotoxin by exposing them to gradually increasing 
numbers of unfed, adult, female I. holocyclus over 
a 6-week period prior to the first tick challenge 
on Day 98. Dogs in the IVP group had previously 
demonstrated hyperimmunisation to holocyclo-
toxin, but did not undergo re-immunisation prior 
to application of the collars on Day 0, due to the 
expected waning of immunity during the period 
from Day 0 until the commencement of tick infes-
tations on Day 98. 
At all times, IVP- and placebo-treated dogs were 
kept separate and study personnel followed 
1 Wongaburra Research Centre, Yorklea, NSW, Australia
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appropriate measures to prevent transfer of chemi-
cal between treated and control dogs. Dogs were 
exercised in outdoor, grassed runs with other dogs 
from the same treatment group for at least 30 min 
on days that they were not infested with ticks and 
weather permitting. Dogs were acclimated to their 
pens for 7 days before the studies commenced. In 
the first study, the dogs were housed individually 
in pens from Day –7 to 94, except between Days 
63 to 67 and 77 to 80, when the dogs in the placebo 
group were housed in pairs. This study commenced 
in summer (December) and finished in autumn 
(April), and the temperature in the pens ranged 
from 17 °C to 37 °C. In the second study, dogs from 
the same treatment group were housed in group 
pens of six to eight dogs between Days –7 to 91, 
and then in pairs between Days 91 to 227. This 
study commenced in early spring (September) and 
finished in autumn (May), and the ambient tem-
perature ranged from 7 °C to 37 °C2.
In the first study, dogs were ranked from greatest 
to least according to their tick-carrying capacity, 
which was tested on Day –7, and then assigned to 
the IVP or placebo group alternately. The dog with 
the greatest tick-carrying capacity was allocated to 
2 Temperature at closest station to Wongaburra Research 
Centre (Casino Airport; station 058208), recorded by the 
Australian Government, Bureau of Meteorology
Table 1 Overview of experimental design and activities
Day Activity STUDY 1
–14
Selection of study dogs, dogs washed (Natural shampoo; Dermcare Vet Pty Ltd), placebo collars fitted to all 
dogs to condition them to wearing collars
–7 Tick carrying capacity (TCC) test commenced: attached 30 ticks to each dog
–5
Ticks counted, but left in place to boost immunity. Dogs ranked according to TCC. Allocation of dogs to 
treatment groups, groups to pens and dogs within groups to pens
–1 Ticks removed
0 Acclimation collars removed. Collars fitted to IVP (n = 8) and placebo (n = 8) dogs
14 Tick challenge: attached 30 ticks to placebo (n = 8) and IVP (n = 8) treated dogs
15 Counted ticks
16 Counted ticks
17 Counted and removed ticks
42 Tick challenge: attached 30 ticks to placebo (n = 8) and IVP (n = 8) treated dogs
43 Counted ticks
44 Counted ticks
45 Counted ticks, but ticks left in place on all dogs until 86 h
46 Counted and removed ticks at 86 h
70 Tick challenge: attached 30 ticks to placebo (n = 8) and IVP (n = 8) treated dogs
71 Counted ticks
72 Counted ticks
73 Counted and removed ticks
84 Tick challenge: attached 30 ticks to placebo (n = 8) and IVP (n = 6) treated dogs
85 Counted ticks
86 Counted ticks
87 Counted and removed ticks
94 Study 1 concluded
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treatment group randomly, initiating the sequence 
of treatment group allocation of the remaining dogs. 
Each treatment group was randomly allocated to 
one of two pen blocks within the kennel, and within 
treatment group, dogs were randomly allocated to 
individual pens within block. In the second study, 
dogs were allocated to treatment group based on 
social compatibility, as dogs were housed in groups 
(Day –7 to 91) or in pairs (Day 91–227). On Day 56, 
four of the IVP-treated dogs (n = 12) were randomly 
allocated to a subgroup, IVP reserves. On Day 91, 
each treatment group was randomly allocated to 
Day Activity STUDY 2
–7
Dogs washed (Natural shampoo; Dermcare Vet Pty Ltd)  
Allocation of dogs to treatment groups and groups to pens
0 Collars (IVP) fitted to IVP dogs (n = 12)
56 Allocated four of the IVP-treated dogs to a subgroup, IVP reserves
91 Collars (placebo) fitted to placebo dogs (n = 8)
98 Tick challenge: attached 30 ticks to placebo (n = 8) and IVP (n = 8) treated dogs
99 Counted ticks
100 Counted ticks
101 Counted ticks and removed (IVP dogs) or left in place (placebo dogs)
112 Tick challenge: attached 30 ticks to placebo (n = 8) and IVP (n = 8) treated dogs
113 Counted ticks
114 Counted ticks
115 Counted ticks and removed (IVP dogs) or left in place (placebo dogs)
140 Tick challenge: attached 30 ticks to placebo (n = 8) and IVP (n = 8) treated dogs
141 Counted ticks 
142 Counted ticks
143 Counted and removed ticks
168 Tick challenge: attached 30 ticks to placebo (n = 8) and IVP (n = 8) treated dogs
169 Counted ticks
170 Counted ticks
171 Counted and removed ticks
196 Tick challenge: attached 30 ticks to placebo (n = 9)# and IVP (n = 12)* treated dogs
197 Counted ticks
198 Counted ticks
199 Counted ticks and removed (IVP dogs) or left in place (placebo dogs)
224 Tick challenge: attached 30 ticks to placebo (n = 7)~ and IVP (n = 8) treated dogs
225 Counted ticks
226 Counted ticks
227 Counted and removed ticks. Removed collars
^  Two IVP-treated dogs were withdrawn from the study (on Days 83 and 84) for adverse events unrelated to the test 
product, leaving only six dogs in the IVP-treated group for the tick challenge on Day 84, study 1
*  The IVP-reserve dogs (n = 4) were included in study 2 between Days 196–199
#  An additional dog was included in the placebo group between Days 196–199
~  One placebo-treated dog was withdrawn from the study on Day 206 for treatment of tick paralysis, leaving only seven 
dogs in the placebo-treated group for the tick challenge on Day 224
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one of two pen blocks within the kennel and within 
each treatment group, pairs of dogs were allocated 
to individual pens based on social compatibility. 
Random allocation of treatment groups and dogs 
was respectively achieved by blindly drawing from 
a hat one of two labelled coins or a ball of paper 
labelled with pen number. 
A collar was fitted to the neck of each dog in the 
IVP (Seresto®; imidacloprid 10 %, flumethrin 4.5 %; 
Bayer Animal Health) and placebo (IVP collar, 
without active ingredients) groups on Day 0 (or 
Day 91 for the placebo dogs in study 2), leaving 
a gap of approximately 2.5 cm between the collar 
and the neck. The excess length of collar was fitted 
through the loops on the collar and a single mat-
tress suture was placed to secure the free end to the 
underlying collar. The collars were retained for the 
duration of the study. Dogs were examined three 
times daily for any signs of ill health and treatment 
sites were visually inspected by the investigator at 
the time of each 72 h tick count.
I. holocyclus collection and infestation
Unfed, adult, female I. holocyclus were collected 
from tick habitats in the northern Rivers region 
of New South Wales (NSW), Australia, and stored 
in a dark incubator at approximately 12 °C for up 
to 199 days before being placed on a dog. In both 
studies, the dogs were infested with ticks at 14 to 
28 day intervals, specifically on Days –7, 14, 42, 56, 
70, 84 (study 1) and Days 98, 112, 140, 168, 196 and 
224 (study 2). At each tick challenge, every dog was 
infested with 30 unfed, adult, female ticks, placed 
on the ears (3 on each), head (5), shoulders (5 on 
each), midline between the shoulders (5), dorsal 
back at the level of the last thoracic vertebra (2) 
and tail base (2). Each tick was manually attached 
to the skin of the dog and attachment verified by 
gently pulling on the tick to ensure insertion of its 
hypostome. In most cases, ticks did not move from 
their initial site of attachment. To avoid contami-
nating placebo-treated dogs with chemicals from 
the IVP-treated dogs, ticks were attached to all 
placebo dogs before the IVP-treated dogs and the 
investigators changed overalls between treatment 
groups and washed hands with a non-acaricidal 
soap between dogs.
Assessing efficacy
The number of ticks remaining on dogs 24, 48 and 72 
(± 4) h after infestation was assessed by digital pal-
pation and visual inspection by two or three expe-
rienced study personnel. Searching commenced in 
areas furthest away from the treatment site, in 
those areas where ticks were manually attached 
and extended towards the head so that the whole 
dog was searched. Ticks were classified into one 
of seven categories, as described in Table 2. The 
ticks were counted in situ and classified, but left 
in place at the 24 h and 48 h post infestation tick 
counts and removed at the 72 h count. The ticks 
remaining on the placebo dogs 72 h post infestation 
on Days 98, 112 and 196 were not removed until the 
following tick challenge, to re-stimulate these dogs’ 
Table 2 Classification of ticks according to their state of survival, attachment and engorgement*
Category Survival status Attachment status Acaricidal effect
1 Live Free, unattached Not demonstrated
2 Live Attached, unengorged Not demonstrated
3 Live Attached, engorging Not demonstrated
4 Dead Free, unattached Yes
5 Dead Attached, unengorged Yes
6 Dead Attached, engorging Yes
7 Dead Attached, engorged Not demonstrated
* Adapted from Marchiondo et al. (2007)
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immunity to holocyclotoxin. Acaricidal efficacy was 
calculated using geometric mean numbers of ticks, 
as recommended by Marchiondo et al. (2007):
Acaricidal efficacy (%) = 100 x (Gmc – Gmt)/Gmc
Gmc =  Geometric mean number of live and dead 
engorged ticks (categories 1–3 and 7) on dogs in 
the placebo group at a specific time point.
Gmt =  Geometric mean number of live and dead 
engorged ticks (categories 1–3 and 7) on dogs in 
the IVP group at a specific time point.
Data analysis
Descriptive statistics (mean, median, range and 
95 % confidence intervals (CI)) were calculated for 
the efficacy data using Microsoft Excel (2010).
Animal ethics and approval
Approval to conduct this study was granted by 
the NSW Department of Primary Industry Direc-
tor General’s Animal Care and Ethics Commit-
tee (09/4103) and the Australian Pesticides and 
Veterinary Medicines Authority General Permit 
PER7250. 
Results 
The acaricidal efficacy of the IVP against I. holocy-
clus at 72 h post infestation exceeded 95 % on Days 
17 (99.3 %), 59 (99.7 %), 73 (96.6 %), 87 (100.0 %), 
101 (96.4 %), 115 (99.1 %) and 171 (95.8 %), but was 
lower on Days 45 (94.0 %) and 143 (77.8 %), and 
declined from Day 199 (79.9 %) to 227 (65.5 %) (see 
Table 3 and Figs. 1 and 2). The mean efficacy 72 h 
post infestation was 97.9 % over the first 115 days 
and 91.3 % over 227 days after collar application. 
The mean efficacy 48 h post infestation was 93.2 % 
over the first 115 days and 81.9 % over 226 days 
after collar application. The mean efficacy 24 h post 
infestation was 81.1 % over the first 115 days and 
72.0 % over 225 days after collar application. The 
mean number of live ticks counted on IVP-treated 
and placebo-treated dogs 72 h post infestation 
ranged from 0 to 7.1 and 15.4 to 26.4, respectively. 
As ticks were removed at 72 h post infestation, no 
Table 3  Treatment efficacy and mean number of live and 
dead engorged I. holocyclus on dogs treated with 






Placebo c IVP d
Efficacy 
(%)
15 24 24.7 7.4 70.2
16 48 24.1 0.9 96.4
17 72 21.7 0.1 99.3
43 24 25.2 2.1 91.6
44 48 24.3 2.6 89.4
45 72 24.6 1.5 94.0
57 24 26.9 7.4 72.7
58 48 26.6 0.9 96.8
59 72 26.4 0.1 99.7
71 24 25.8 2.9 88.9
72 48 24.6 2.1 91.6
73 72 24.5 0.8 96.6
85 24 25.9 2.4 (6) 90.9
86 48 25.8 1.2 (6) 95.2
87 72 25.0 0.0 (6) 100.0
99 24 26.1 4.8 81.6
100 48 26.0 2.7 89.6
101 72 23.7 0.9 96.4
113 24 26.0 7.3 71.9
114 48 25.5 1.7 93.5
115 72 22.2 0.2 99.1
141 24 23.8 8.5 64.3
142 48 22.3 6.0 73.2
143 72 19.1 4.2 77.8
169 24 19.5 3.6 81.6
170 48 18.3 1.9 89.7
171 72 15.4 0.6 95.8
197 24 21.2 (9) 11.5 (12) 46.1
198 48 19.0 (9) 9.9 (12) 48.0
199 72 16.7 (9) 3.3 (12) 79.9
225 24 24.1 (7) 16.3 32.2
226 48 22.7 (7) 14.2 37.5
227 72 20.6 (7) 7.1 65.5
a  Collars (IVP or placebo) were fitted to dogs on Day 0
b  Each dog was infested with 30 unfed, adult,  
female I. holocyclus
c  Geometric mean number of live and dead engorged 
ticks (categories 1–3 and 7) on placebo-treated dogs 
(n = 8 dogs, except where indicated by the italicised 
number in brackets)
d  Geometric mean number of live and dead engorged 
ticks (categories 1–3 and 7) on IVP-treated dogs 




engorged ticks (live or dead) were seen on any IVP-
treated dog. No adverse events related to treat-
ment were observed during the study. Adverse 
events unrelated to treatment occurred in both 
IVP- and placebo-treated groups and included a 
swollen parotid salivary gland, gastric dilation and 
volvulus, tick paralysis and fight wounds and were 
documented and treated.
Discussion 
This study has demonstrated the sustained efficacy 
of the IVP in dogs artificially infested with I. holo-
cyclus, with mean 72 h post infestation efficacies of 
97.9 % over 115 days and 91.3 % over 227 days after 
collar application. These efficacy results are simi-
lar, but not sustained for as long after collar applica-
tion compared to those reported for the IVP against 
other tick species. For example, the efficacy of the 
IVP on dogs at 18 and 48 h post infestation with 50 
(25 male, 25 female) laboratory-bred R. sanguineus 
exceeded 97.8 % from Day 7 until the completion of 
the study on Day 226 (Horak et al. 2012). However, 
to allow for an assessment of repellency 6 h post 
infestation, ticks were not manually attached to 
the dogs in Horak’s study, which likely resulted 
in fewer ticks attaching to the treated dogs and 
lower tick counts compared to the current study. 
Another study that similarly investigated repellent 
efficacy at 6 h post infestation also reported very 
good efficacy in dogs 48 h post infestation against 
I. ricinus (100 %), R. sanguineus (> 97 %), D. reticu-
latus (generally > 97 %) and D. variabilis (> 90 %) 
from Day 2 to Day 240 after application of the IVP 
(Stanneck et al. 2012b). High and sustained acari-
cidal efficacy has also been demonstrated against 
naturally acquired tick infestations, with efficacies 
of 91.2–100 % (mean 94.7 %) over 8 months reported 
in 197 dogs treated with the IVP in a European 
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Fig. 1  Geometric mean number of live and dead engorged ticks (categories 1–3 and 7) on placebo-treated dogs 
(n = 7–9) or IVP-treated dogs (n = 6–12) 72 h after artificial infestation. Each dog was infested with 30 unfed, 
adult, female I. holocyclus
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multicentre clinical field study (Stanneck et al. 
2012d).
The current study was designed to assess the acari-
cidal efficacy of the test product to support the Aus-
tralian registration of the IVP for the prevention 
of tick paralysis induced by I. holocyclus. For this 
reason, each tick was manually attached to the dog 
ensuring insertion of its hypostome, a method not 
conducive to assessing repellency, as the ticks are 
not required to move through the hair to voluntar-
ily attach to the dog. With regard to the acaricidal 
efficacy this test represents an artificial, worst case 
scenario as ticks are much more likely to acquire 
a lethal dose of the active ingredient while moving 
though the hair coat in a natural setting before 
finally attaching to the animal.  This design gives 
us a clearer understanding of the acaricidal efficacy 
of the test product even under maximally unfavour-
able conditions (a tick attaching immediately to the 
spot of its first animal contact), whilst it disregards 
the repellent properties of pyrethroids that have 
been demonstrated for ticks in both in vitro (e.g. 
moving object bioassay) (Dautel and Cranna 2006) 
and in vivo studies (Horak et al. 2012, Stanneck 
et al. 2012b).
As the adult, female I. holocyclus feed, they inject 
toxins into their host that can cause fatal paralysis 
in dogs. It is therefore critical that ticks are killed 
or their ability to feed impaired prior to the onset 
of clinical signs of paralysis, which may be seen as 
early as the fourth day after attachment (Clunies 
Ross 1935) and on average 6.2 days post infesta-
tion (Ilkiw et al. 1987). This corresponds to findings 
that the quantity of toxin secreted by the ticks’ sali-
vary glands increases rapidly from the third day of 
feeding (Goodrich and Murray 1978) and justifies 
the timing of the tick counts for calculation of acari-
cidal efficacy in this study. A tick killed by 72 h post 
infestation is unlikely to have induced paralysis 
in its host, making this a clinically relevant and 
standard time to determine efficacy against I. holo-
cyclus (Webster et al. 2011).
Time since application of collar (months)
24 h post infestation
48 h post infestation
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Fig. 2  Efficacy of the IVP collar against I. holocyclus over 8 months
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An evaluation of efficacy against I. holocyclus on 
IVP-treated dogs following shampooing or swim-
ming was beyond the scope of this current study, 
but has been previously assessed for other tick spe-
cies. Stanneck et al. (2012b) found that the effi-
cacy of the IVP in dogs that were shampooed or 
immersed in water every 28 days remained above 
97 % and 94 %, respectively, against R. sanguineus 
and above 90 % and 89 %, respectively, against 
D. variabilis, over a period of 8 months. These 
results suggest that the active acaricidal compound 
remains in or on the hair and skin, or are replen-
ished from the collar and thus support an assump-
tion that regular shampooing or swimming should 
not markedly reduce the IVP’s acaricidal efficacy 
against I. holocyclus. 
A limitation of this study was that dogs were 
housed in pairs for some of the tick challenges 
(between Days 91 to 227), potentially allowing dogs 
to remove ticks from their pen-mates, reducing tick 
counts. It was suspected that grooming by the pen-
mate (dog 9) was responsible for the declining tick 
counts in one placebo-treated dog (dog 67) of 17, 
11, 9 and 3, 72 h post infestation on Days 101, 115, 
143 and 171, respectively. To test this hypothesis, 
dog 62 was substituted for dog 67 and housed with 
dog 9 for the tick challenge commencing on Day 
196 and similarly exhibited a very low tick count 
(3) 72 h post infestation. At the tick challenge sub-
sequent to separation from dog 9 (Day 224), dog 
62 had a higher 72 h post infestation tick count, 
suggesting that dog 9 had previously removed ticks 
by grooming her pen-mates. This occurrence may 
explain the declining tick counts observed in the 
placebo group mean tick counts from Days 98–168.
There were no adverse events related to the IVP in 
this study, which supports the safety data already 
compiled through field trials and long-term safety 
studies in dogs and puppies. In a European field 
study, only 3 of 271 IVP-treated dogs exhibited 
treatment-related adverse events over the 8 month 
study period, and these were confined to minor, 
local reactions at the collar site (Stanneck et al. 
2012d).




This study has demonstrated the excellent acari-
cidal efficacy (mean = 97.9 %) of the IVP against 
I. holocyclus 72 h post infestation over 16 weeks.
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